top of page
Leadership Team

Insightful. Experienced. Entrepreneurial.

PIC Therapeutics' team of passionate leaders, board members and advisors brings well over 100 years of combined biopharmaceutical experience in research and development, launching innovative companies and cultivating their growth, and delivering breakthrough medicines to patients. We have also assembled a network of strategic partnerships with leading consultants and contractors, allowing us to benefit from their scale to efficiently and expeditiously advance our program.

Dr. Kathy Bowdish

Dr. Kathy Bowdish

President & CEO

F. Andrew Dorr

F. Andrew Dorr

Chief Medical Officer

Janice Lansita, Ph. D.

Janice Lansita, Ph. D.

Toxicology

Summer Busto

Summer Busto

Human Capital Advisor

Richard Gedrich

Richard Gedrich

Chief Development Officer

Lisa Sturla, Ph. D.

Lisa Sturla, Ph. D.

Head of In Vitro Pharmacology

Dr. Debra Vallner

Dr. Debra Vallner

Project Manager

Chris VanDeusen, Ph. D.

Chris VanDeusen, Ph. D.

VP & Chief Scientific Officer

Susan E. Alters, Ph. D.

Susan E. Alters, Ph. D.

Head of In Vivo Pharmacology

Christine Magyar

Christine Magyar

Finance

bottom of page